Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069104 · ClinicalTrials.gov registry record
Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 1,849
- Enrollment target
NCT04069104: Completed study, sponsored by University of Miami.
NCT04069104 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 1,849 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04069104 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 1,849 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate an interactive game designed to increase people's ability to identify cancerous moles.
Primary Outcome
Mole identification accuracy will be reported as the amount of mole correctly identified as either melanoma or typical nevi
Interventions
- BEHAVIORAL ABCD Information
- BEHAVIORAL UDS information
- BEHAVIORAL Standard (clinical) feedback
- BEHAVIORAL Motivational feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,849 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2021-03-03 |
What the finished NCT04069104 record still lists
NCT04069104 is an observational study that tracks outcomes without assigning an intervention. Its 1,849 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which ABCD Information is the first listed.
NCT04069104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04069104 about?
NCT04069104 is a clinical study titled "Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification". The purpose of this study is to evaluate an interactive game designed to increase people's ability to identify cancerous moles.
What is the current status of trial NCT04069104?
This trial is currently completed. The enrollment target is 1,849 participants. The study started on 2020-11-13. Estimated completion is 2021-03-03.
What interventions are being tested in trial NCT04069104?
The interventions under investigation include: ABCD Information (BEHAVIORAL), UDS information (BEHAVIORAL), Standard (clinical) feedback (BEHAVIORAL), Motivational feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT04069104?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI